Royce & Associates’s Pelagos Insurance Capital PLGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.2M Sell
471,892
-608,048
-56% -$15M 0.1% 323
2026
Q2
$26.3M Sell
1,079,940
-109,561
-9% -$2.38M 0.21% 154
2026
Q1
$22.7M Buy
1,189,501
+2,288
+0.2% +$43.8K 0.22% 121
2025
Q4
$23.2M Sell
1,187,213
-404,046
-25% -$7.53M 0.24% 126
2025
Q3
$28.9M Buy
1,591,259
+1,525,868
+2,333% +$25.5M 0.29% 97
2025
Q2
$1.08M Buy
+65,391
New +$1.08M 0.01% 664

Other funds holding PLGO

Royce & Associates's PLGO Position: Q3 2026 in Review

Royce & Associates reduced its Pelagos Insurance Capital (PLGO) stake by 56% in Q3 2026, selling an estimated $15M and leaving 471,892 shares worth $11.2M. The position accounts for 0.1% of the portfolio, ranked #323.

Royce & Associates first reported a position in PLGO in Q2 2025 and has held it in 6 quarters since. The position peaked at $28.9M in Q3 2025. 106 funds tracked by Wall St. Rank hold PLGO as of Q3 2026.

  • Royce & Associates held 471,892 shares of Pelagos Insurance Capital worth $11.2M as of Q3 2026.
  • Royce & Associates sold 608,048 Pelagos Insurance Capital shares in Q3 2026, an estimated $15M.
  • Pelagos Insurance Capital made up 0.1% of Royce & Associates's portfolio in Q3 2026, its #323 holding.
  • Royce & Associates first reported a position in Pelagos Insurance Capital in Q2 2025 and has held it in 6 quarters since.
  • Royce & Associates's Pelagos Insurance Capital position peaked at $28.9M in Q3 2025.
  • 106 funds tracked by Wall St. Rank held Pelagos Insurance Capital as of Q3 2026.

Based on Royce & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.